Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: Synthesis of Ligands for somatostatin receptors

被引:23
作者
Chianelli, D
Kim, YC
Lvovskiy, D
Webb, TR
机构
[1] ChemBridge Res Labs LLC, San Diego, CA 92127 USA
[2] ChemBridge Corp, San Diego, CA 92127 USA
关键词
D O I
10.1016/j.bmc.2003.08.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonpeptide compounds that mimic bioactive peptides are desirable for a number of clinical indications. We report a new practical method for the design of scaffolds exhibiting drug-like properties that are suitable for the display of peptide pharmacophores. The synthesis of various synthons of 7'-hydroxy-2',3'-dihydro-1'H,2H,5H-spiro[imidazolidine-4,4'-quinoline]-2,5-dione (1) and methods for the introduction of several mimics of amino acid side-chains are described. This method is exemplified by derivatives that show agonist activity for the somatostatin type 2 receptor. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5059 / 5068
页数:10
相关论文
共 23 条
[1]  
ADANG AEP, 1994, RECL TRAV CHIM PAY B, V113, P63
[2]  
Ball J B, 1990, J Mol Recognit, V3, P55, DOI 10.1002/jmr.300030202
[3]   A solid-phase approach to mouse melanocortin receptor agonists derived from a novel thioether cyclized peptidomimetic scaffold [J].
Bondebjerg, J ;
Xiang, ZM ;
Bauzo, RM ;
Haskell-Luevano, C ;
Meldal, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (37) :11046-11055
[4]  
CRIDER M, 2002, J MED CHEM, V45, P507
[5]   Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chloropheny)-3-(2-(dimethylamino)ethyl)isochroman-1-one (AC-7954) [J].
Croston, GE ;
Olsson, R ;
Currier, EA ;
Burstein, ES ;
Weiner, D ;
Nash, N ;
Severance, D ;
Allenmark, SG ;
Thunberg, L ;
Ma, JN ;
Mohell, N ;
O'Dowd, B ;
Brann, MR ;
Hacksell, U .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :4950-4953
[6]   Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine [J].
Evans, DA ;
Katz, JL ;
West, TR .
TETRAHEDRON LETTERS, 1998, 39 (19) :2937-2940
[7]   CHARACTERIZATION OF SOMATOSTATIN RECEPTORS IN GUINEA-PIG ISOLATED ILEUM, VAS-DEFERENS AND RIGHT ATRIUM [J].
FENIUK, W ;
DIMECH, J ;
HUMPHREY, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1156-1164
[8]   Design criteria for molecular mimics of fragments of the β-turn.: 1.: Cα atom analysis [J].
Garland, SL ;
Dean, PM .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1999, 13 (05) :469-483
[9]   Compounds that activate the mouse melanocortin-1 receptor identified by screening a small molecule library based upon the β-turn [J].
Haskell-Luevano, C ;
Rosenquist, Å ;
Souers, A ;
Khong, KC ;
Ellman, JA ;
Cone, RD .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (21) :4380-4387
[10]   DE-NOVO DESIGN AND SYNTHESIS OF SOMATOSTATIN NONPEPTIDE PEPTIDOMIMETICS UTILIZING BETA-D-GLUCOSE AS A NOVEL SCAFFOLDING [J].
HIRSCHMANN, R ;
NICOLAOU, KC ;
PIETRANICO, S ;
LEAHY, EM ;
SALVINO, J ;
ARISON, B ;
CICHY, MA ;
SPOORS, PG ;
SHAKESPEARE, WC ;
SPRENGELER, PA ;
HAMLEY, P ;
SMITH, AB ;
REISINE, T ;
RAYNOR, K ;
MAECHLER, L ;
DONALDSON, C ;
VALE, W ;
FREIDINGER, RM ;
CASCIERI, MR ;
STRADER, CD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (26) :12550-12568